US Stock MarketDetailed Quotes

SRTS Sensus Healthcare

Watchlist
  • 4.770
  • +0.080+1.71%
Close Mar 28 16:00 ET
  • 4.650
  • -0.120-2.52%
Post 19:55 ET
78.68MMarket Cap11.63P/E (TTM)

Sensus Healthcare Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
61.26%-831K
-131.00%-827K
794.34%3.95M
470.08%4.23M
-36.52%-8.19M
-51.91%-2.15M
126.38%2.67M
-88.13%442K
-60.86%742K
-294.58%-6M
Net income from continuing operations
1,270.52%6.65M
-63.28%1.55M
183.74%1.22M
524.21%1.61M
220.06%2.27M
-98.00%485K
48.82%4.21M
-179.33%-1.45M
-110.78%-380K
-111.79%-1.89M
Operating gains losses
----
----
----
----
----
99.67%-42K
--0
----
----
----
Depreciation and amortization
-6.29%432K
26.42%134K
-3.77%102K
-39.06%78K
-2.48%118K
-9.43%461K
-12.40%106K
-52.25%106K
72.97%128K
31.52%121K
Deferred tax
86.65%-57K
--0
-342.40%-553K
33.93%-331K
203.12%827K
75.07%-427K
1,001.80%1M
-105.84%-125K
---501K
78.58%-802K
Change In working capital
-140.28%-8.55M
5.91%-2.8M
72.08%3.17M
108.88%2.73M
-212.42%-11.65M
72.45%-3.56M
78.43%-2.98M
363.75%1.84M
171.33%1.31M
-209.04%-3.73M
-Change in receivables
-238.54%-9.21M
26.37%-2.77M
-44.74%1.25M
-63.96%1.29M
-296.67%-8.98M
225.08%6.65M
62.56%-3.76M
-22.33%2.26M
1,462.88%3.58M
187.17%4.57M
-Change in inventory
103.12%268K
-9.19%1.13M
105.10%162K
148.67%1.84M
-0.35%-2.87M
-168.79%-8.58M
207.45%1.24M
-347.67%-3.17M
-690.19%-3.79M
-45.00%-2.86M
-Change in prepaid assets
-111.02%-361K
-269.17%-1.62M
-41.33%1.61M
-88.51%338K
79.67%-685K
168.60%3.28M
131.17%960K
383.10%2.74M
220.14%2.94M
-1,911.83%-3.37M
-Change in payables and accrued expense
155.32%1.98M
171.69%838K
1,087.93%689K
53.80%-456K
161.36%910K
-312.02%-3.58M
-190.27%-1.17M
101.76%58K
-188.60%-987K
-136.84%-1.48M
-Change in other current assets
13.52%-467K
157.45%27K
-533.67%-425K
134.66%96K
47.45%-165K
-283.67%-540K
49.46%-47K
-74.68%98K
---277K
---314K
-Change in other current liabilities
9.95%-181K
0.00%-49K
2.08%-47K
20.69%-46K
15.22%-39K
-1.01%-201K
-8.89%-49K
68.83%-48K
---58K
---46K
-Change in other working capital
-0.34%-585K
-130.07%-352K
28.71%-72K
-228.16%-338K
178.32%177K
59.20%-583K
77.76%-153K
75.66%-101K
-217.05%-103K
45.41%-226K
Cash from discontinued investing activities
Operating cash flow
61.26%-831K
-131.00%-827K
794.34%3.95M
470.08%4.23M
-36.52%-8.19M
-51.91%-2.15M
126.38%2.67M
-88.13%442K
-60.86%742K
-294.58%-6M
Investing cash flow
Cash flow from continuing investing activities
-47.59%-276K
297K
-1,187.10%-337K
89.66%-3K
-23.28%-233K
-101.26%-187K
0
151.67%31K
35.56%-29K
-101.26%-189K
Net PPE purchase and sale
-20.52%-276K
--297K
-2,963.64%-337K
89.66%-3K
-23.28%-233K
-44.03%-229K
--0
81.67%-11K
35.56%-29K
-329.55%-189K
Net other investing changes
----
----
----
----
----
-99.72%42K
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
-47.59%-276K
--297K
-1,187.10%-337K
89.66%-3K
-23.28%-233K
-101.26%-187K
--0
151.67%31K
35.56%-29K
-101.26%-189K
Financing cash flow
Cash flow from continuing financing activities
137.50%15K
500.00%28K
23.08%-30K
17K
0
98.35%-40K
99.64%-7K
-118.48%-39K
0
-97.80%6K
Net common stock issuance
--0
--0
----
----
----
99.10%-27K
--0
----
----
----
Proceeds from stock option exercised by employees
45.65%67K
--33K
--17K
--17K
--0
-93.71%46K
--0
--0
--0
-86.74%46K
Net other financing activities
11.86%-52K
28.57%-5K
----
----
----
45.87%-59K
---7K
86.05%-12K
--0
-73.91%-40K
Cash from discontinued financing activities
Financing cash flow
137.50%15K
500.00%28K
23.08%-30K
--17K
--0
98.35%-40K
99.64%-7K
-118.48%-39K
--0
-97.80%6K
Net cash flow
Beginning cash position
-9.29%23.15M
10.11%22.56M
-5.39%18.97M
-23.85%14.73M
-9.29%23.15M
75.77%25.52M
-45.48%20.49M
-40.50%20.05M
-41.09%19.34M
75.77%25.52M
Current changes in cash
53.96%-1.09M
-118.87%-502K
726.27%3.59M
495.23%4.24M
-36.25%-8.42M
-121.56%-2.37M
122.07%2.66M
-88.80%434K
-18.33%713K
-133.75%-6.18M
End cash Position
-4.72%22.06M
-4.72%22.06M
10.11%22.56M
-5.39%18.97M
-23.85%14.73M
-9.29%23.15M
-9.29%23.15M
-45.48%20.49M
-40.50%20.05M
-41.09%19.34M
Free cash flow
53.37%-1.11M
-119.87%-530K
738.98%3.62M
492.85%4.23M
-36.11%-8.42M
-51.11%-2.37M
126.36%2.67M
-88.23%431K
-61.48%713K
-303.62%-6.19M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 61.26%-831K-131.00%-827K794.34%3.95M470.08%4.23M-36.52%-8.19M-51.91%-2.15M126.38%2.67M-88.13%442K-60.86%742K-294.58%-6M
Net income from continuing operations 1,270.52%6.65M-63.28%1.55M183.74%1.22M524.21%1.61M220.06%2.27M-98.00%485K48.82%4.21M-179.33%-1.45M-110.78%-380K-111.79%-1.89M
Operating gains losses --------------------99.67%-42K--0------------
Depreciation and amortization -6.29%432K26.42%134K-3.77%102K-39.06%78K-2.48%118K-9.43%461K-12.40%106K-52.25%106K72.97%128K31.52%121K
Deferred tax 86.65%-57K--0-342.40%-553K33.93%-331K203.12%827K75.07%-427K1,001.80%1M-105.84%-125K---501K78.58%-802K
Change In working capital -140.28%-8.55M5.91%-2.8M72.08%3.17M108.88%2.73M-212.42%-11.65M72.45%-3.56M78.43%-2.98M363.75%1.84M171.33%1.31M-209.04%-3.73M
-Change in receivables -238.54%-9.21M26.37%-2.77M-44.74%1.25M-63.96%1.29M-296.67%-8.98M225.08%6.65M62.56%-3.76M-22.33%2.26M1,462.88%3.58M187.17%4.57M
-Change in inventory 103.12%268K-9.19%1.13M105.10%162K148.67%1.84M-0.35%-2.87M-168.79%-8.58M207.45%1.24M-347.67%-3.17M-690.19%-3.79M-45.00%-2.86M
-Change in prepaid assets -111.02%-361K-269.17%-1.62M-41.33%1.61M-88.51%338K79.67%-685K168.60%3.28M131.17%960K383.10%2.74M220.14%2.94M-1,911.83%-3.37M
-Change in payables and accrued expense 155.32%1.98M171.69%838K1,087.93%689K53.80%-456K161.36%910K-312.02%-3.58M-190.27%-1.17M101.76%58K-188.60%-987K-136.84%-1.48M
-Change in other current assets 13.52%-467K157.45%27K-533.67%-425K134.66%96K47.45%-165K-283.67%-540K49.46%-47K-74.68%98K---277K---314K
-Change in other current liabilities 9.95%-181K0.00%-49K2.08%-47K20.69%-46K15.22%-39K-1.01%-201K-8.89%-49K68.83%-48K---58K---46K
-Change in other working capital -0.34%-585K-130.07%-352K28.71%-72K-228.16%-338K178.32%177K59.20%-583K77.76%-153K75.66%-101K-217.05%-103K45.41%-226K
Cash from discontinued investing activities
Operating cash flow 61.26%-831K-131.00%-827K794.34%3.95M470.08%4.23M-36.52%-8.19M-51.91%-2.15M126.38%2.67M-88.13%442K-60.86%742K-294.58%-6M
Investing cash flow
Cash flow from continuing investing activities -47.59%-276K297K-1,187.10%-337K89.66%-3K-23.28%-233K-101.26%-187K0151.67%31K35.56%-29K-101.26%-189K
Net PPE purchase and sale -20.52%-276K--297K-2,963.64%-337K89.66%-3K-23.28%-233K-44.03%-229K--081.67%-11K35.56%-29K-329.55%-189K
Net other investing changes ---------------------99.72%42K--0------------
Cash from discontinued investing activities
Investing cash flow -47.59%-276K--297K-1,187.10%-337K89.66%-3K-23.28%-233K-101.26%-187K--0151.67%31K35.56%-29K-101.26%-189K
Financing cash flow
Cash flow from continuing financing activities 137.50%15K500.00%28K23.08%-30K17K098.35%-40K99.64%-7K-118.48%-39K0-97.80%6K
Net common stock issuance --0--0------------99.10%-27K--0------------
Proceeds from stock option exercised by employees 45.65%67K--33K--17K--17K--0-93.71%46K--0--0--0-86.74%46K
Net other financing activities 11.86%-52K28.57%-5K------------45.87%-59K---7K86.05%-12K--0-73.91%-40K
Cash from discontinued financing activities
Financing cash flow 137.50%15K500.00%28K23.08%-30K--17K--098.35%-40K99.64%-7K-118.48%-39K--0-97.80%6K
Net cash flow
Beginning cash position -9.29%23.15M10.11%22.56M-5.39%18.97M-23.85%14.73M-9.29%23.15M75.77%25.52M-45.48%20.49M-40.50%20.05M-41.09%19.34M75.77%25.52M
Current changes in cash 53.96%-1.09M-118.87%-502K726.27%3.59M495.23%4.24M-36.25%-8.42M-121.56%-2.37M122.07%2.66M-88.80%434K-18.33%713K-133.75%-6.18M
End cash Position -4.72%22.06M-4.72%22.06M10.11%22.56M-5.39%18.97M-23.85%14.73M-9.29%23.15M-9.29%23.15M-45.48%20.49M-40.50%20.05M-41.09%19.34M
Free cash flow 53.37%-1.11M-119.87%-530K738.98%3.62M492.85%4.23M-36.11%-8.42M-51.11%-2.37M126.36%2.67M-88.23%431K-61.48%713K-303.62%-6.19M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Petroleo Brasileiro SA Petrobras
PBR
-0.07%
Vale SA
VALE
-1.28%
Ecopetrol
EC
-1.64%
Taylor Morrison Home
TMHC
-2.11%
KB Home
KBH
-2.50%

Unlock the Full List